T. Justin Rettenmaier

Vice President, Head Of Early Discovery at Jnana Therapeutics

Justin Rettenmaier is a highly experienced professional in the field of chemical biology. Justin has held various roles in different companies, including Jnana Therapeutics and Whitehead Institute. Justin's research has focused on topics such as site-directed ligand discovery and new methods for synthesis. Justin holds a Ph.D. in Chemical Biology from UCSF and a BS in Chemistry from the University of California, Santa Cruz.

Links

Org chart

Timeline

  • Vice President, Head Of Early Discovery

    July 1, 2023 - present

  • Senior Director, Head of Early Discovery

    October, 2022

  • Director, Chemical Biology

    July, 2021

  • Associate Director, Chemical Biology

    December, 2019

  • Principal Scientist, Chemical Biology

    October, 2018

  • Senior Scientist, Chemical Biology

    June, 2017

View in org chart